Interaction in vitro of pulmonary surfactant with antifungal agents used for treatment and prevention of invasive aspergillosis.
Kerstin K RauwolfCaroline HoertnaglCornelia Lass-FloerlAndreas H GrollPublished in: The Journal of antimicrobial chemotherapy (2021)
Using EUCAST methodology, addition of porcine surfactant up to a concentration of 10% had a minor, and presumably non-relevant, impact on the in vitro activity of antifungal agents used in prophylaxis and treatment of invasive pulmonary aspergillosis.